Marker Therapeutics, Inc.

NasdaqCM:MRKR Stock Report

Market Cap: US$27.8m

Marker Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:MRKR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
19 Aug 25SellUS$21,489John WilsonIndividual18,100US$1.23
15 Aug 25SellUS$148,428John WilsonIndividual121,299US$1.29

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of MRKR?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,237,7037.42%
VC/PE Firms1,625,6789.75%
Institutions2,387,47914.3%
General Public11,422,26768.5%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 55.7%.

Top Shareholders

Top 25 shareholders own 30.72% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.75%
New Enterprise Associates, Inc.
1,625,678US$2.7m0%0.12%
3.85%
John Wilson
641,801US$1.1m0%no data
3.32%
CHI Advisors LLC
554,250US$925.6k0%0.4%
2.08%
The Vanguard Group, Inc.
346,074US$577.9k15.4%no data
1.95%
Aisling Capital Management LP
325,370US$543.4k0%0.1%
1.6%
Juan Vera
267,184US$446.2k0%no data
1.04%
UBS Asset Management AG
174,026US$290.6k2,900%no data
0.89%
NewEdge Advisors, LLC
149,000US$248.8k0%no data
0.78%
Geode Capital Management, LLC
130,344US$217.7k35.3%no data
0.74%
Renaissance Technologies LLC
123,650US$206.5k16.4%no data
0.59%
Two Sigma Investments, LP
98,141US$163.9k169%no data
0.5%
LPL Financial LLC
83,247US$139.0k41.7%no data
0.49%
Osaic Wealth, Inc.
81,319US$135.8k19.6%no data
0.35%
Citadel Advisors LLC
58,847US$98.3k0%no data
0.35%
XTX Markets Limited
58,041US$96.9k167%no data
0.27%
Scott Sandell
44,403US$74.2k0%no data
0.27%
Forest Baskett
44,403US$74.2k0%no data
0.27%
Paul Walker
44,403US$74.2k0%no data
0.27%
I-Hua Chang
44,403US$74.2k0%no data
0.27%
Mohamad Makhzoumi
44,403US$74.2k0%no data
0.27%
Anthony Florence
44,403US$74.2k0%no data
0.27%
Ali Behbahani
44,403US$74.2k0%no data
0.24%
Jane Street Group, LLC
40,518US$67.7k0%no data
0.16%
Invst, LLC
27,000US$45.1k-6.9%no data
0.16%
Northern Trust Global Investments
26,009US$43.4k140%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/21 14:26
End of Day Share Price 2026/04/21 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Marker Therapeutics, Inc. is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yun ZhongBrean Capital Historical (Janney Montgomery)
Leah Rush CannBrookline Capital Markets
John NewmanCanaccord Genuity